TBIO Financial Facts
LOSS FROM OPERATIONS: -1.62MNET LOSS: -1.93M
See Full Income Statement
Total liabilities: 19.9M
Total stockholders’ equity: -17.82M
See Full Balance Sheet
Transgenomic (TBIO) Earnings
|
Expand Research on TBIO
| Next EPS Date | 5/8/24 | EPS Growth Rate | +37.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +11.1% | Revenue Growth Rate | +10.9% |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.23 | N/A | N/A | $7M | N/A | N/A | N/A | ||
| 3/19/24 | Q423 | N/A | -$0.27 | N/A | N/A | $9.5M | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.27 | N/A | N/A | $9.5M | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.30 | N/A | N/A | $7.4M | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | -$0.37 | -$0.30 | -$0.07 | $5.6M | $7.4M | N/A |  | | Details | |
8/10/23  |
Q223 | N/A | -$0.32 | N/A | N/A | $8.6M | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | -$0.37 | -$0.38 | +$0.01 | $6.31M | $6.8M | N/A | | | Details | |
| 3/21/23 | Q422 | -$0.28 | -$0.41 | +$0.13 | $9.5M | $7.2M | N/A | | | Details |
